Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Song Mao, Xianguo Ren & Jianhua Zhang. (2016) The emerging role of fibroblast growth factor 21 in diabetic nephropathy. Journal of Receptors and Signal Transduction 36:6, pages 586-592.
Read now
Read now
Articles from other publishers (39)
Federica Conti, Serena Di Martino, Filippo Drago, Claudio Bucolo, Vincenzo Micale, Vincenzo Montano, Gabriele Siciliano, Michelangelo Mancuso & Piervito Lopriore. (2023) Red Flags in Primary Mitochondrial Diseases: What Should We Recognize?. International Journal of Molecular Sciences 24:23, pages 16746.
Crossref
Crossref
Valeria Di Leo, Conor Lawless, Marie-Pier Roussel, Tiago B. Gomes, Gráinne S. Gorman, Oliver M. Russell, Helen A.L. Tuppen, Elise Duchesne & Amy E. Vincent. (2023) Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1. Journal of Neuromuscular Diseases 10:6, pages 1111-1126.
Crossref
Crossref
Nneka Southwell, Guido Primiano, Viraj Nadkarni, Nabeel Attarwala, Emelie Beattie, Dawson Miller, Sumaitaah Alam, Irene Liparulo, Yevgeniya I Shurubor, Maria Lucia Valentino, Valerio Carelli, Serenella Servidei, Steven S Gross, Giovanni Manfredi, Qiuying Chen & Marilena D'Aurelio. (2023) A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy. EMBO Molecular Medicine 15:7.
Crossref
Crossref
Kyung-Mi Choi, Karen K Ryan & John C Yoon. (2022) Adipose Mitochondrial Complex I Deficiency Modulates Inflammation and Glucose Homeostasis in a Sex-Dependent Manner. Endocrinology 163:4.
Crossref
Crossref
W.H.G. Hubens, A. Vallbona-Garcia, I.F.M. de Coo, F.H.J. van Tienen, C.A.B. Webers, H.J.M. Smeets & T.G.M.F. Gorgels. (2022) Blood biomarkers for assessment of mitochondrial dysfunction: An expert review. Mitochondrion 62, pages 187-204.
Crossref
Crossref
Xue Zhou, Yuefeng Zhang & Ning Wang. (2021) Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease. Frontiers in Physiology 12.
Crossref
Crossref
Aimin Wu, Bin Feng, Jie Yu, Lijun Yan, Lianqiang Che, Yong Zhuo, Yuheng Luo, Bing Yu, De Wu & Daiwen Chen. (2021) Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biology 46, pages 102131.
Crossref
Crossref
Phuc Phan, Bibhuti Ballav Saikia, Shivakumar Sonnaila, Shilpi Agrawal, Zeina Alraawi, Thallapuranam Krishnaswamy Suresh Kumar & Shilpa Iyer. (2021) The Saga of Endocrine FGFs. Cells 10:9, pages 2418.
Crossref
Crossref
Han Fang, Sujoy Ghosh, Landon C. Sims, Kirsten P. Stone, Cristal M. Hill, Denisha Spires, Daria V. Ilatovskaya, Christopher D. Morrison, Thomas W. Gettys & Krisztian Stadler. (2021) FGF21 prevents low-protein diet-induced renal inflammation in aged mice. American Journal of Physiology-Renal Physiology 321:3, pages F356-F368.
Crossref
Crossref
Akshata Huddar, Periyasamy Govindaraj, Shwetha Chiplunkar, Sekar Deepha, J.N. Jessiena Ponmalar, Mariyamma Philip, Madhu Nagappa, Gayathri Narayanappa, Anita Mahadevan, Sanjib Sinha, Arun B. Taly & Bindu Parayil Sankaran. (2021) Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders. Mitochondrion 60, pages 170-177.
Crossref
Crossref
João Victor Salgado, Miguel Angelo Goes & Natalino Salgado Filho. (2021) FGF21 and Chronic Kidney Disease. Metabolism 118, pages 154738.
Crossref
Crossref
Yasunori Fujita, Masafumi Ito & Ikuroh Ohsawa. (2020) Mitochondrial stress and GDF15 in the pathophysiology of sepsis. Archives of Biochemistry and Biophysics 696, pages 108668.
Crossref
Crossref
Yan Lin, Kunqian Ji, Xiaotian Ma, Shuangwu Liu, Wei Li, Yuying Zhao & Chuanzhu Yan. (2020) Accuracy of FGF‐21 and GDF‐15 for the diagnosis of mitochondrial disorders: A meta‐analysis. Annals of Clinical and Translational Neurology 7:7, pages 1204-1213.
Crossref
Crossref
Christine M. Kusminski, Alexandra L. Ghaben, Thomas S. Morley, Ricardo J. Samms, Andrew C. Adams, Yu An, Joshua A. Johnson, Nolwenn Joffin, Toshiharu Onodera, Clair Crewe, William L. Holland, Ruth Gordillo & Philipp E. Scherer. (2020) A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive β-Cell Hyperplasia. Diabetes 69:3, pages 313-330.
Crossref
Crossref
Mohammad Zarei, Javier Pizarro-Delgado, Emma Barroso, Xavier Palomer & Manuel Vázquez-Carrera. (2020) Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis. Trends in Pharmacological Sciences 41:3, pages 199-208.
Crossref
Crossref
Yeboah Kwaku Opoku, Zhihang Liu, Justice Afrifa, Mir Hassan Khoso, Guiping Ren & Deshan Li. (2019) Therapeutic Role of Fibroblast Growth Factor 21 (FGF21) in the Amelioration of Chronic Diseases. International Journal of Peptide Research and Therapeutics 26:1, pages 107-119.
Crossref
Crossref
Paulo Giovani de Albuquerque Suassuna, Paula Marocolo Cherem, Bárbara Bruna de Castro, Edgar Maquigussa, Marco Antonio Cenedeze, Júlio Cesar Moraes Lovisi, Melani Ribeiro Custódio, Helady Sanders-Pinheiro & Rogério Baumgratz de Paula. (2019) αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats. Experimental Biology and Medicine 245:1, pages 66-78.
Crossref
Crossref
Femke Molema, Monique Williams, Janneke Langendonk, Sarwa Darwish‐Murad, Jacqueline van de Wetering, Ed Jacobs, Willem Onkenhout, Esther Brusse, Anke van der Eerden & Margreet Wagenmakers. (2020) Neurotoxicity including posterior reversible encephalopathy syndrome after initiation of calcineurin inhibitors in transplanted methylmalonic acidemia patients: Two case reports and review of the literature. JIMD Reports 51:1, pages 89-104.
Crossref
Crossref
Polina G. Tsygankova, Yulia S. Itkis, Tatiana D. Krylova, Marina V. Kurkina, Igor O. Bychkov, Aleksandra A. Ilyushkina, Viktoria V. Zabnenkova, Svetlana V. Mikhaylova, Natalia L. Pechatnikova, Natalia L. Sheremet & Ekaterina Y. Zakharova. (2019) Plasma FGF‐21 and GDF‐15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders. Journal of Inherited Metabolic Disease 42:5, pages 918-933.
Crossref
Crossref
Paulo Giovanni de Albuquerque Suassuna, Rogério Baumgratz de Paula, Hélady Sanders-Pinheiro, Orson W. Moe & Ming-Chang Hu. (2018) Fibroblast growth factor 21 in chronic kidney disease. Journal of Nephrology 32:3, pages 365-377.
Crossref
Crossref
N. L. Sheremet, N. A. Andreeva, M. S. Shmel'kova & P. G. Tsigankova. (2019) Mitochondrial biogenesis in hereditary optic neuropathies. Vestnik oftal'mologii 135:5, pages 85.
Crossref
Crossref
S. Koene, C. Jimenez-Moreno & G. S. Gorman. 2019. Diagnosis and Management of Mitochondrial Disorders. Diagnosis and Management of Mitochondrial Disorders
317
329
.
F. Molema, E. H. Jacobs, W. Onkenhout, G. C. Schoonderwoerd, J. G. Langendonk & Monique Williams. (2018) Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias. Journal of Inherited Metabolic Disease 41:6, pages 1179-1187.
Crossref
Crossref
Joan Villarroya, Laura Campderros, Francesc Ribas-Aulinas, Audrey Carrière, Louis Casteilla, Marta Giralt & Francesc Villarroya. (2018) Lactate induces expression and secretion of fibroblast growth factor-21 by muscle cells. Endocrine 61:1, pages 165-168.
Crossref
Crossref
Ricardo Moure, Pere Domingo, Joan Villarroya, Laura Gasa, José M. Gallego-Escuredo, Tania Quesada-López, Samantha Morón-Ros, Alberto F. Maroto, Gracia M. Mateo, Joan C. Domingo, Francesc Villarroya & Marta Giralt. (2018) Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System. Antimicrobial Agents and Chemotherapy 62:6.
Crossref
Crossref
Darla R. Shores & Allen D. Everett. (2018) Children as Biomarker Orphans: Progress in the Field of Pediatric Biomarkers. The Journal of Pediatrics 193, pages 14-20.e31.
Crossref
Crossref
Michelangelo Mancuso, Robert McFarland, Thomas Klopstock, Michio Hirano, Rafael Artuch, Enrico Bertini, Laurence Bindoff, Valerio Carelli, Grainne Gorman, Michio Hirano, Rita Horvath, Petra Kaufmann, Thomas Klopstock, Yasutoshi Koga, Saskia Koene, Costanza Lamperti, Robert McFarland, Michelangelo Mancuso, Julio Montoya, Francisco Javier Pérez-Mínguez Caneda, Vincent Procaccio, Holger Prokisch, Shamima Rahman, Piero Santantonio, Markus Schülke, Serenella Servidei, Dikoma C. Shungu, Gabriele Siciliano, Jan Smeitink, Tanja Taivassalo, John L.P. Thompson, Doug Turnbull, Elja Van der Veer, Philip E. Yeske & Massimo Zeviani. (2017) International Workshop:. Neuromuscular Disorders 27:12, pages 1126-1137.
Crossref
Crossref
Eleftheria Maratos-Flier. (2017) Fatty liver and FGF21 physiology. Experimental Cell Research 360:1, pages 2-5.
Crossref
Crossref
Alireza Morovat, Gayani Weerasinghe, Victoria Nesbitt, Monika Hofer, Thomas Agnew, Geralrine Quaghebeur, Kate Sergeant, Carl Fratter, Nishan Guha, Mehdi Mirzazadeh & Joanna Poulton. (2017) Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice. Journal of Clinical Medicine 6:8, pages 80.
Crossref
Crossref
Kara L. PerksNicola FerreiraTara R. RichmanJudith A. ErmerIrina KuznetsovaAnne-Marie J. ShearwoodRichard G. LeeHelena M. Viola, Victoria P. A. Johnstone, Vance MatthewsLivia C. HoolOliver RackhamAleksandra Filipovska. (2017) Adult-onset obesity is triggered by impaired mitochondrial gene expression. Science Advances 3:8.
Crossref
Crossref
Eleni Paleologou, Naila Ismayilova & Maria Kinali. (2017) Use of the Ketogenic Diet to Treat Intractable Epilepsy in Mitochondrial Disorders. Journal of Clinical Medicine 6:6, pages 56.
Crossref
Crossref
Amel Karaa, Shamima Rahman, Anne Lombès, Patrick Yu‐Wai‐Man, Muniza K. Sheikh, Sherita Alai‐Hansen, Bruce H. Cohen, David Dimmock, Lisa Emrick, Marni J. Falk, Shana McCormack, David Mirsky, Tony Moore, Sumit Parikh, John Shoffner, Tanja Taivassalo, Mark Tarnopolsky, Ingrid Tein, Joanne C. Odenkirchen & Amy Goldstein. (2017) Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project. Journal of Inherited Metabolic Disease 40:3, pages 403-414.
Crossref
Crossref
Miguel Ángel Gómez-Sámano, Mariana Grajales-Gómez, Julia María Zuarth-Vázquez, Ma. Fernanda Navarro-Flores, Mayela Martínez-Saavedra, Óscar Alfredo Juárez-León, Mariana G. Morales-García, Víctor Manuel Enríquez-Estrada, Francisco J. Gómez-Pérez & Daniel Cuevas-Ramos. (2017) Fibroblast growth factor 21 and its novel association with oxidative stress. Redox Biology 11, pages 335-341.
Crossref
Crossref
Corinne Alban, Elena Fatale, Abed Joulani, Polina Ilin & Ann Saada. (2017) The Relationship between Mitochondrial Respiratory Chain Activities in Muscle and Metabolites in Plasma and Urine: A Retrospective Study. Journal of Clinical Medicine 6:3, pages 31.
Crossref
Crossref
Vivek K. Shenoy, Kristin M. Beaver, ffolliott M. Fisher, Garima Singhal, Jody R. Dushay, Eleftheria Maratos-Flier & Sarah N. Flier. (2016) Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis. PLOS ONE 11:11, pages e0164351.
Crossref
Crossref
Ayman W. El-Hattab & Fernando Scaglia. (2016) Mitochondrial cytopathies. Cell Calcium 60:3, pages 199-206.
Crossref
Crossref
Devorah Soiferman & Ann Saada. 2015. The Functions, Disease‐Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria. The Functions, Disease‐Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria
378
398
.
Robert D.S. Pitceathly & Robert McFarland. (2014) Mitochondrial myopathies in adults and children. Current Opinion in Neurology 27:5, pages 576-582.
Crossref
Crossref
Minal J. Menezes, Lisa G. Riley & John Christodoulou. (2014) Mitochondrial respiratory chain disorders in childhood: Insights into diagnosis and management in the new era of genomic medicine. Biochimica et Biophysica Acta (BBA) - General Subjects 1840:4, pages 1368-1379.
Crossref
Crossref